Dermata Therapeutics, Inc. Common Stock Share Price
NASDAQ: DRMAHealthcare
Live Dermata Therapeutics, Inc. Common Stock Share Price Chart
O H L
Dermata Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$1.18Low
$1.18High
Markets Today
| Previous Close | $1.16 |
|---|---|
| Open | $1.18 |
| Volume | 14,270 |
| Day's Range | $1.18 - $1.18 |
| 52W Range | $0.95 - $5.98 |
| Market Cap | $5.70 M |
Historical Performance
| 1M Returns | -18.88 |
|---|---|
| 3M Returns | -0.85 |
| 6M Returns | -2.52 |
| 1Y Returns | -79.76 |
| 5Y Returns | -99.99 |
| 10Y Returns | NA |
Dermata Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $5.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.94 |
| EPS TTM | $-4.51 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.33 |
| EBITDA | $-7.77 M |
| Profit Margin | N/A |
| Market Cap | $5.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.94 |
| EPS TTM | $-4.51 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.33 |
| EBITDA | $-7.77 M |
| Profit Margin | N/A |
Dermata Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$2.34 M | -$1.77 M | -$1.76 M | -$1.90 M | -$1.93 M | -$3.01 M |
| EBITDA | -$2.34 M | -$1.77 M | -$1.76 M | -$1.90 M | -$1.93 M | -$3.01 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $0 | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$2.30 M | -$1.70 M | -$1.69 M | -$1.86 M | -$1.85 M | -$2.97 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$2.30 M | -$1.70 M | -$1.69 M | -$1.86 M | -$1.85 M | -$2.97 M |
| Net Profit Margin | - | - | - | - | - | - |
Dermata Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $603 | $64 | $84 | $266 | $402 | $402 |
| Reserve & Surplus | -$67.98 M | -$69.68 M | -$71.37 M | -$73.23 M | -$75.08 M | -$78.05 M |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Liabilities | $2.70 M | $1.03 M | $1.11 M | $1.64 M | $1.05 M | $1.83 M |
| Total Liabilities | $2.70 M | $1.03 M | $1.11 M | $1.64 M | $1.05 M | $1.83 M |
| Fixed Assets | $0 | $0 | $0 | $0 | $0 | $129.37 K |
| Current Assets | $10.01 M | $6.64 M | $5.07 M | $7.86 M | $7.47 M | $5.16 M |
| Total Assets | $10.01 M | $6.64 M | $5.07 M | $7.86 M | $7.47 M | $5.32 M |
Dermata Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$2.30 M | -$1.70 M | -$1.69 M | -$1.86 M | -$1.85 M | -$2.97 M |
| Operating Cash Flow | -$1.93 M | -$2.69 M | -$1.80 M | -$1.33 M | -$2.48 M | -$2.42 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | -$110.67 K |
| Financing Cash Flow | $8.49 M | -$547.86 K | -$12.99 K | $4.19 M | $1.90 M | -$323 |
| Change in Cash | $6.56 M | -$3.24 M | -$1.82 M | $2.86 M | -$576.70 K | -$2.53 M |
Dermata Therapeutics, Inc. Common Stock Return Calculator
The Dermata Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1
Invested Amount$10,000
Est. Returns$-9,999
About Dermata Therapeutics, Inc. Common Stock
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.
Popular Stocks
FAQs
What is the share price of Dermata Therapeutics, Inc. Common Stock today?
Dermata Therapeutics, Inc. Common Stock (DRMA) share price as of September 18, 2026 is $1.14. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Dermata Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Dermata Therapeutics, Inc. Common Stock (DRMA) Share by opening an international trading account with Angel One.
How can I purchase Dermata Therapeutics, Inc. Common Stock shares in India?
Purchasing Dermata Therapeutics, Inc. Common Stock (DRMA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Dermata Therapeutics, Inc. Common Stock (DRMA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Dermata Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Dermata Therapeutics, Inc. Common Stock (DRMA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Dermata Therapeutics, Inc. Common Stock?
The market capitalization of Dermata Therapeutics, Inc. Common Stock on September 18, 2026, is $5.70 M.
In which sector Dermata Therapeutics, Inc. Common Stock belongs?
Dermata Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Dermata Therapeutics, Inc. Common Stock stocks?
In order to invest in Dermata Therapeutics, Inc. Common Stock (DRMA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
